NASDAQ:CMPX

Compass Therapeutics Stock Predictions

etoro logo Buy CMPX
*Your capital is at risk
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CMPX Prediction Chart

CMPX Predictions History

Latest community submissions for CMPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 8, 2025 $1.64 +4.40% $1.59 V 96.91% 1
Apr 8, 2025 Bullish $1.59 V 1
Mar 26, 2025 $2.25 +3.89% $2.04 X 89.49% 0
Mar 26, 2025 $2.22 +2.35% $2.04 X 91.13% 0
Mar 26, 2025 $4.06 +71.31% $2.04 X 0.98% 0
Mar 13, 2025 Bullish $2.47 X 0
Mar 4, 2025 $2.85 +4.47% $2.78 V 97.41% 1
Mar 4, 2025 $2.81 +2.79% $2.78 V 99.06% 2
Mar 4, 2025 $3.94 +35.86% $2.78 X 58.27% 1
Mar 3, 2025 $3.02 +4.17% $2.73 X 89.35% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPASS THERAPEUTICS, INC.
Compass Therapeutics
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE